JPH07265066A - Peptone for culture medium for culturing microorganism - Google Patents
Peptone for culture medium for culturing microorganismInfo
- Publication number
- JPH07265066A JPH07265066A JP6085567A JP8556794A JPH07265066A JP H07265066 A JPH07265066 A JP H07265066A JP 6085567 A JP6085567 A JP 6085567A JP 8556794 A JP8556794 A JP 8556794A JP H07265066 A JPH07265066 A JP H07265066A
- Authority
- JP
- Japan
- Prior art keywords
- peptone
- medium
- protein
- culture medium
- royal jelly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000001888 Peptone Substances 0.000 title claims abstract description 47
- 108010080698 Peptones Proteins 0.000 title claims abstract description 47
- 235000019319 peptone Nutrition 0.000 title claims abstract description 47
- 239000001963 growth medium Substances 0.000 title claims abstract description 23
- 244000005700 microbiome Species 0.000 title claims abstract description 14
- 238000012258 culturing Methods 0.000 title abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 27
- 229940109850 royal jelly Drugs 0.000 claims abstract description 24
- 239000012528 membrane Substances 0.000 claims description 9
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 32
- 241000894006 Bacteria Species 0.000 abstract description 19
- 235000014655 lactic acid Nutrition 0.000 abstract description 16
- 239000004310 lactic acid Substances 0.000 abstract description 16
- 238000010438 heat treatment Methods 0.000 abstract description 15
- 239000000203 mixture Substances 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 230000002411 adverse Effects 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 41
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 23
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 229940088598 enzyme Drugs 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 18
- 241000186000 Bifidobacterium Species 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000008213 purified water Substances 0.000 description 10
- 238000006911 enzymatic reaction Methods 0.000 description 9
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 8
- 102100034866 Kallikrein-6 Human genes 0.000 description 8
- 108010073771 Soybean Proteins Proteins 0.000 description 8
- 235000020183 skimmed milk Nutrition 0.000 description 8
- 235000019710 soybean protein Nutrition 0.000 description 8
- 241001608472 Bifidobacterium longum Species 0.000 description 7
- 229940009291 bifidobacterium longum Drugs 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000005018 casein Substances 0.000 description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
- 235000021240 caseins Nutrition 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003531 protein hydrolysate Substances 0.000 description 5
- 239000012460 protein solution Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000194020 Streptococcus thermophilus Species 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000004365 Protease Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 235000010378 sodium ascorbate Nutrition 0.000 description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 3
- 229960005055 sodium ascorbate Drugs 0.000 description 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 235000013861 fat-free Nutrition 0.000 description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 229960001322 trypsin Drugs 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 230000002289 effect on microbe Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Landscapes
- Jellies, Jams, And Syrups (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、ローヤルゼリー由来の
蛋白質を酵素で処理した蛋白質加水分解物からなる微生
物培養培地用ペプトンに関する。この微生物培養培地用
ペプトンは、ビフィズス菌あるいは乳酸菌の生育促進に
優れた効果を有するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a peptone for a microbial culture medium comprising a protein hydrolyzate obtained by treating a protein derived from royal jelly with an enzyme. This peptone for a microorganism culture medium has an excellent effect on the growth promotion of bifidobacteria or lactic acid bacteria.
【0002】[0002]
【従来の技術】従来、微生物を培養する培地の窒素源と
して用いられているペプトンは、ミルクカゼイン、獣
肉、心筋、ゼラチン、大豆蛋白質などの蛋白質をトリプ
シン、ペプシン、パパイン、膵液などの酵素で加水分解
して調製されている。しかし、窒素源としてこれらのペ
プトンを用いても、栄養要求性の高い乳酸菌やビフィズ
ス菌などでは生育が十分でない場合がある。そこで、ビ
タミンなどの発酵促進効果を有する成分を培地に微量加
えることが行われているが、一般に乳酸菌を培養する際
に用いられている10〜12%濃度の還元脱脂乳培地にペプ
トンや各種ビタミンなどを添加してもあまり生育の良く
ない乳酸菌も存在する。BACKGROUND ART Peptone, which has been conventionally used as a nitrogen source for a medium for culturing microorganisms, hydrolyzes proteins such as milk casein, meat, heart muscle, gelatin and soybean protein with enzymes such as trypsin, pepsin, papain and pancreatic juice. It is prepared by disassembling. However, even if these peptones are used as the nitrogen source, the growth may not be sufficient for lactic acid bacteria and bifidobacteria, which have high auxotrophy. Therefore, it is practiced to add trace amounts of components such as vitamins having a fermentation promoting effect to the medium, but peptone and various vitamins are added to the reduced skim milk medium of 10 to 12% concentration that is generally used when lactic acid bacteria are cultured. There are also lactic acid bacteria that do not grow well even when such substances are added.
【0003】[0003]
【発明が解決しようとする課題】このような理由から、
各種ビタミンやその他の発酵促進物質を豊富に含む酵母
エキスが乳酸菌の生育促進物質として用いられている。
しかし、酵母エキスは高価であり、しかも酵母臭などを
伴うことから、製品への風味に影響しないようにごくわ
ずかの量しか培地に添加できないという問題があった。
従って本発明は、カゼインや大豆蛋白質等の加水分解物
よりも、ビフィズズ菌や乳酸菌の増殖あるいは発酵促進
に効果があり、かつ製品の風味に悪影響を与えないロー
ヤルゼリー由来の蛋白質を酵素で処理した微生物培養培
地用ペプトンを提供することを課題とするものである。
また本発明は、従来廃棄されていたローヤルゼリー由来
の蛋白質を微生物培養培地用ペプトンとして用いること
により、資源の有効活用を図ることも課題とするもので
ある。For these reasons,
Yeast extract rich in various vitamins and other fermentation promoting substances is used as a growth promoting substance for lactic acid bacteria.
However, since yeast extract is expensive and is accompanied by yeast odor, there is a problem that only a very small amount can be added to the medium so as not to affect the flavor of the product.
Therefore, the present invention, than a hydrolyzate such as casein and soybean protein, is effective in promoting the growth or fermentation of bifidobacteria and lactic acid bacteria, and does not adversely affect the flavor of the product microorganisms treated with an enzyme protein derived from royal jelly It is an object to provide peptone for a culture medium.
Another object of the present invention is to effectively utilize resources by using a conventionally-discarded protein derived from royal jelly as a peptone for a microorganism culture medium.
【0004】[0004]
【課題を解決するための手段】本発明は、ローヤルゼリ
ー由来の蛋白質の酵素加水分解物からなる微生物培養培
地用ペプトンである。ローヤルゼリー由来の蛋白質は、
調製ローヤルゼリーを製造する過程で生ローヤルゼリー
を限外ろ過膜(以下UF膜という)や精密ろ過膜(以下
MF膜という)処理することにより得られる蛋白質を
用いることができる。この蛋白質は、調製ローヤルゼリ
ーを製造する際に、天然のローヤルゼリーにアルコール
を加えて流動性を良くした後、分画分子量2万程度のU
F膜や孔径5μm以下のMF膜で処理したとき濃縮側に
回収される残渣である。このようにして得られた蛋白質
含有溶液は、pHが 4.6前後と低く、アルコール分も約7
%含まれている蛋白質含有組成物である。また蛋白質も
全固形分中約70%程度含有しており、不溶性の状態にあ
る。DISCLOSURE OF THE INVENTION The present invention is a peptone for a microorganism culture medium, which comprises an enzymatic hydrolyzate of a protein derived from royal jelly. The protein from royal jelly is
A protein obtained by subjecting raw royal jelly to an ultrafiltration membrane (hereinafter referred to as UF membrane) or a microfiltration membrane (hereinafter referred to as MF membrane) in the process of producing a prepared royal jelly can be used. When producing a prepared royal jelly, this protein was added to the natural royal jelly with alcohol to improve fluidity, and then the U with a molecular weight cut-off of about 20,000 was used.
It is a residue recovered on the concentration side when treated with an F membrane or an MF membrane having a pore size of 5 μm or less. The protein-containing solution thus obtained has a low pH of around 4.6 and has an alcohol content of about 7
% Of the protein-containing composition. Also, protein is contained in about 70% of the total solid content, and is in an insoluble state.
【0005】得られた蛋白質含有組成物を酵素で加水分
解する際には、酵素反応に影響しない範囲で加温(10〜
70℃程度)し、pHを3以下あるいは7以上に調整して酵
素反応を行う。使用可能な酵素については、特に限定さ
れず通常蛋白質を加水分解する際に用いる酵素を使用す
ることができる。例えば植物由来の酵素であれば、パパ
インやブロメラインであり、動物由来の酵素であれば、
トリプシン、キモトリプシンである。更には微生物由来
の酵素の場合には、プロテアーゼM(天野製薬社製)、
オリエターゼ20A (阪急共栄物産社製)等が挙げられ
る。 これらの酵素の中から一種またはそれ以上を選択
して用いる。酵素の添加量は、蛋白質1g当たり 150〜40
0 単位程度で、用いる酵素の至適温度及び至適pHに従っ
て22時間程度反応を行うと良い。また、酵素反応の停止
は、85℃で20分間程度加熱することにより行うことがで
きる。このようにして得られた蛋白質加水分解物を、微
生物培養用培地に0.01%以上配合して用いる。また必要
に応じてビタミンなどを培地に添加しても良い。更に
は、上記のようにして調製した蛋白質加水分解物を、通
常の方法に従って乾燥することにより、粉末状培地用ペ
プトンとすることができる。この粉末状培地用ペプトン
は、水に対する溶解性がよく、またエタノール溶液に対
しても可溶性を有している。When the obtained protein-containing composition is hydrolyzed with an enzyme, heating (10 to 10
Then, the pH is adjusted to 3 or less or 7 or more and the enzymatic reaction is performed. The enzyme that can be used is not particularly limited, and an enzyme that is usually used when hydrolyzing a protein can be used. For example, if it is a plant-derived enzyme, it is papain or bromelain, and if it is an animal-derived enzyme,
Trypsin and chymotrypsin. Further, in the case of a microorganism-derived enzyme, Protease M (manufactured by Amano Pharmaceutical Co., Ltd.)
Orientase 20A (manufactured by Hankyu Kyoei Bussan Co., Ltd.) and the like. One or more of these enzymes are selected and used. The amount of enzyme added is 150-40 per gram of protein.
It is advisable to carry out the reaction for about 22 hours according to the optimum temperature and optimum pH of the enzyme used in about 0 unit. Moreover, the enzymatic reaction can be stopped by heating at 85 ° C. for about 20 minutes. The protein hydrolyzate thus obtained is used by adding 0.01% or more to a microorganism culture medium. In addition, vitamins and the like may be added to the medium as needed. Further, the protein hydrolyzate prepared as described above can be dried according to a usual method to obtain peptone for a powdery medium. This peptone for a powdery medium has good solubility in water and is also soluble in an ethanol solution.
【0006】以下に実施例、比較例および実験例を示
し、本発明を具体的に説明する。(%は重量%を表
す。)The present invention will be described in detail below with reference to Examples, Comparative Examples and Experimental Examples. (% Represents% by weight.)
実施例1 固形率が20%となるようアルコールに溶解した生ローヤ
ルゼリー溶液を分画分子量2万のUF膜で処理し、蛋白
質を6%含有する溶液を得た。このローヤルゼリー蛋白
質含有溶液 (pH 4.6) 200gを1N塩酸でpH 3.0に調整し
た。この溶液を45℃に加温した後、プロテアーゼM(天
野製薬社製)を蛋白質1g 当たり 180単位加え、45℃で
22時間酵素反応を行った。そして、85℃で20分間加熱し
て酵素を失活させた後、室温まで冷却し、10N水酸化ナ
トリウムでpHを 6.8に調整した。最後に、この加水分解
物を凍結乾燥して培地用ペプトン11g を得た。Example 1 A raw royal jelly solution dissolved in alcohol to a solid content of 20% was treated with a UF membrane having a molecular weight cut off of 20,000 to obtain a solution containing 6% of protein. 200 g of this royal jelly protein-containing solution (pH 4.6) was adjusted to pH 3.0 with 1N hydrochloric acid. After heating this solution to 45 ° C, 180 units of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.) was added per 1 g of protein, and at 45 ° C
The enzymatic reaction was performed for 22 hours. Then, after heating at 85 ° C. for 20 minutes to inactivate the enzyme, it was cooled to room temperature and the pH was adjusted to 6.8 with 10N sodium hydroxide. Finally, the hydrolyzate was freeze-dried to obtain 11 g of culture medium peptone.
【0007】実施例2 実施例1と同様にして得られたローヤルゼリー蛋白質溶
液300gを1.2 N塩酸でpH 3.0に調整した。この溶液を45
℃に加温した後、プロテアーゼM(天野製薬社製)を蛋
白質1g当たり 360単位加え、45℃で22時間酵素反応を行
った。そして、85℃で20分間加熱して酵素を失活させた
後、室温まで冷却し、10N水酸化ナトリウムでpHを 6.8
に調整した。最後に、この加水分解物を凍結乾燥して培
地用ペプトン16g を得た。Example 2 300 g of the royal jelly protein solution obtained in the same manner as in Example 1 was adjusted to pH 3.0 with 1.2 N hydrochloric acid. 45 this solution
After heating to 0 ° C., 360 units of protease M (manufactured by Amano Pharmaceutical Co., Ltd.) was added per 1 g of protein, and the enzyme reaction was carried out at 45 ° C. for 22 hours. Then, heat at 85 ° C for 20 minutes to inactivate the enzyme, then cool to room temperature and adjust the pH to 6.8 with 10N sodium hydroxide.
Adjusted to. Finally, the hydrolyzate was freeze-dried to obtain 16 g of culture medium peptone.
【0008】実施例3 実施例1と同様にして得られたローヤルゼリー蛋白質溶
液300gを10N水酸化ナトリウムでpH 7.0に調整した。こ
の溶液を45℃に加温した後、プロテアーゼM(天野製薬
社製)を蛋白質1g当たり 360単位加え、45℃で22時間
酵素反応を行った。そして、85℃で20分間加熱して酵素
を失活させた後、室温まで冷却し、10N水酸化ナトリウ
ムでpHを 6.8に調整した。最後に、この加水分解物を凍
結乾燥して培地用ペプトン17g を得た。Example 3 300 g of the royal jelly protein solution obtained in the same manner as in Example 1 was adjusted to pH 7.0 with 10N sodium hydroxide. After heating this solution to 45 ° C., 360 units of protease M (manufactured by Amano Pharmaceutical Co., Ltd.) was added per 1 g of protein, and the enzyme reaction was carried out at 45 ° C. for 22 hours. Then, after heating at 85 ° C. for 20 minutes to inactivate the enzyme, it was cooled to room temperature and the pH was adjusted to 6.8 with 10N sodium hydroxide. Finally, this hydrolyzate was freeze-dried to obtain 17 g of culture medium peptone.
【0009】以下に、実験例に用いる培地用ペプトンの
調製方法を説明する。それを比較例として示す。The method for preparing the peptone for the medium used in the experimental examples will be described below. It is shown as a comparative example.
比較例1 蛋白質を14.5%含有する生ローヤルゼリー (pH 4.3) 10
0gを1N塩酸でpH 3.0に調整した後、精製水を加えて20
0gに定量した。この溶液を45℃に加温した後、プロテア
ーゼM(天野製薬社製)を蛋白質1g当たり 180単位加
え、45℃で22時間酵素反応を行った。そして、85℃で20
分間加熱して酵素を失活させた後、室温まで冷却し、10
N水酸化ナトリウムでpHを 6.8に調整した。最後に、こ
の加水分解物を凍結乾燥して培地用ペプトン32g を得
た。Comparative Example 1 Raw royal jelly containing 14.5% protein (pH 4.3) 10
After adjusting 0 g to pH 3.0 with 1N hydrochloric acid, add purified water and add 20 g.
It was quantified to 0 g. After heating this solution to 45 ° C., 180 units of protease M (manufactured by Amano Pharmaceutical Co., Ltd.) was added per 1 g of protein, and the enzyme reaction was carried out at 45 ° C. for 22 hours. And 20 at 85 ° C
Heat for minutes to inactivate the enzyme, then cool to room temperature and
The pH was adjusted to 6.8 with N sodium hydroxide. Finally, the hydrolyzate was freeze-dried to obtain 32 g of culture medium peptone.
【0010】比較例2 5%カゼイン溶液300gを1N塩酸でpH 3.0に調整した。
この溶液を45℃に加温した後、プロテアーゼM(天野製
薬社製)をカゼイン1g当たり 180単位加え、45℃で22時
間酵素反応を行った。そして、85℃で20分間加熱して酵
素を失活させた後、室温まで冷却し、10N水酸化ナトリ
ウムでpHを 6.8に調整した。最後に、この加水分解物を
凍結乾燥して培地用ペプトン14g を得た。Comparative Example 2 300 g of a 5% casein solution was adjusted to pH 3.0 with 1N hydrochloric acid.
After heating this solution to 45 ° C., 180 units of protease M (manufactured by Amano Pharmaceutical Co., Ltd.) was added per 1 g of casein, and the enzyme reaction was carried out at 45 ° C. for 22 hours. Then, after heating at 85 ° C. for 20 minutes to inactivate the enzyme, it was cooled to room temperature and the pH was adjusted to 6.8 with 10N sodium hydroxide. Finally, this hydrolyzate was freeze-dried to obtain 14 g of culture medium peptone.
【0011】比較例3 5%大豆蛋白質溶液300gを1N塩酸でpH 3.0に調整し
た。この溶液を45℃に加温した後、プロテアーゼM(天
野製薬社製)を大豆蛋白質1g当たり 180単位加え、45℃
で22時間酵素反応を行った。そして、85℃で20分間加熱
して酵素を失活させた後、室温まで冷却し、10N水酸化
ナトリウムでpHを 6.8に調整した。最後に、この加水分
解物を凍結乾燥して培地用ペプトン15g を得た。Comparative Example 3 300 g of a 5% soybean protein solution was adjusted to pH 3.0 with 1N hydrochloric acid. After heating this solution to 45 ° C, add 180 units of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.) per 1g of soybean protein, and add 45 ° C.
The enzyme reaction was performed for 22 hours. Then, after heating at 85 ° C. for 20 minutes to inactivate the enzyme, it was cooled to room temperature and the pH was adjusted to 6.8 with 10N sodium hydroxide. Finally, the hydrolyzate was freeze-dried to obtain 15 g of culture medium peptone.
【0012】比較例4 5%大豆蛋白質溶液300gを1N塩酸でpH 3.0に調整し
た。この溶液を45℃に加温した後、プロテアーゼM(天
野製薬社製)を大豆蛋白質1g当たり 360単位加え、45℃
で22時間酵素反応を行った。そして、85℃で20分間加熱
して酵素を失活させた後、室温まで冷却し、10N水酸化
ナトリウムでpHを 6.8に調整した。最後に、この加水分
解物を凍結乾燥して培地用ペプトン15g を得た。Comparative Example 4 300 g of a 5% soybean protein solution was adjusted to pH 3.0 with 1N hydrochloric acid. After heating this solution to 45 ° C, add 360 units of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.) per 1 g of soybean protein, and add 45 ° C.
The enzyme reaction was performed for 22 hours. Then, after heating at 85 ° C. for 20 minutes to inactivate the enzyme, it was cooled to room temperature and the pH was adjusted to 6.8 with 10N sodium hydroxide. Finally, the hydrolyzate was freeze-dried to obtain 15 g of culture medium peptone.
【0013】実施例および比較例で得られた培地用ペプ
トンについて、ビフィズス菌および乳酸菌を用いてこの
効果を確認した。その試験例を以下に示す。With respect to the peptone for the medium obtained in Examples and Comparative Examples, this effect was confirmed using Bifidobacteria and lactic acid bacteria. The test example is shown below.
試験例1 実施例1及び比較例1で得られた培地用ペプトンを用
い、ビフィズス菌の生育試験を行った。試験に用いたビ
フィズス菌は、ビフィドバクテリウム・ロンガム(Bifid
obacterium longum) SBT-2928株 (FERM P-10657) 及び
ビフィドバクテリウム・ロンガム (Bifidobacterium lo
ngum) SBT-2933R株 (FERM P-8743)の混合物で、培地に
0.3%接種し、37℃で培養を行った。なお、用いた培地
の組成は、それぞれ脱脂粉乳 11.53%、培地用ペプトン
0.5%及び精製水 87.97%であった。その結果、比較例
1の培地用ペプトンを用いた場合、18時間培養後のpHは
4.96で酸度は0.68であったのに対し、実施例1の培地用
ペプトンを用いた場合、16時間培養後のpHは4.71、酸度
は0.77であり、ビフィズス菌の生育は実施例1で得られ
た培地の方が良好であった。したがって、生ローヤルゼ
リーの加水分解物よりローヤルゼリーをUF膜処理した
蛋白質溶液の加水分解物の方が生育促進効果が高かっ
た。Test Example 1 Using the peptone for a medium obtained in Example 1 and Comparative Example 1, a growth test of bifidobacteria was performed. Bifidobacteria used in the test were Bifidobacteria longum ( Bifid
obacterium longum) SBT-2928 strain (FERM P-10657) and Bifidobacterium longum (Bifidobacterium lo
ngum ) SBT-2933R strain (FERM P-8743) mixture in the medium
0.3% was inoculated and cultured at 37 ° C. The composition of the media used was 11.53% skim milk powder and peptone for the media.
It was 0.5% and purified water 87.97%. As a result, when the medium peptone of Comparative Example 1 was used, the pH after culturing for 18 hours was
Whereas the acidity at 4.96 was 0.68, when the medium peptone of Example 1 was used, the pH after 16-hour culture was 4.71, the acidity was 0.77, and the growth of Bifidobacterium was obtained in Example 1. The culture medium was better. Therefore, the hydrolyzate of the protein solution obtained by subjecting the royal jelly to the UF membrane had a higher growth promoting effect than the hydrolyzate of raw royal jelly.
【0014】試験例2 実施例3で得られた培地用ペプトンを用い、添加量の違
いによるビフィズス菌の生育試験を行った。試験に用い
たビフィズス菌は、ビフィドバクテリウム・ロンガム
(Bifidobacterium longum) SBT-2928株 (FERM P-10657)
及びビフィドバクテリウム・ロンガム (Bifidobacteri
um longum) SBT-2933R株 (FERM P-8743)の混合物で、
培地に 0.3%接種し、37℃で16時間培養を行った。な
お、用いた培地の組成は、(1) 脱脂粉乳 11.03%、培地
用ペプトン 1.0%、アスコルビン酸ナトリウム0.03%及
び精製水 87.94%、(2) 脱脂粉乳 11.53%、培地用ペプ
トン 0.5%、アスコルビン酸ナトリウム0.03%及び精製
水 87.94%、(3) 脱脂粉乳 12.03%、アスコルビン酸ナ
トリウム0.03%及び精製水 87.94%であった。培養後の
酸度を表1に示す。Test Example 2 Using the culture medium peptone obtained in Example 3, a growth test of bifidobacteria was carried out by varying the addition amount. Bifidobacteria used in the test are Bifidobacterium longum
( Bifidobacterium longum ) SBT-2928 strain (FERM P-10657)
And Bifidobacteri longum
um longum ) SBT-2933R strain (FERM P-8743),
The medium was inoculated with 0.3% and cultured at 37 ° C for 16 hours. The composition of the medium used was (1) skim milk powder 11.03%, medium peptone 1.0%, sodium ascorbate 0.03% and purified water 87.94%, (2) skim milk powder 11.53%, medium peptone 0.5%, ascorbic acid. Sodium 0.03% and purified water 87.94%, (3) skim milk powder 12.03%, sodium ascorbate 0.03% and purified water 87.94%. The acidity after culturing is shown in Table 1.
【0015】[0015]
【表1】 (単位:%) ─────────────────────────── 培地 (1) 1.34 培地 (2) 0.94 培地 (3) 0.38 (培地用ペプトン無添加) ─────────────────────────── 表1から明らかなように、本発明の培地用ペプトンはそ
の添加量が多い程微生物の生育に好結果をもたらすこと
が分かる。[Table 1] (Unit:%) ─────────────────────────── Medium (1) 1.34 Medium (2) 0.94 Medium (3) 0.38 (without addition of peptone for medium) ─────────────────────────── As is clear from Table 1, the peptone for medium of the present invention is It can be seen that the larger the amount added, the better the results for the growth of microorganisms.
【0016】試験例3 実施例3で得られた培地用ペプトンを用い、添加量の違
いによる各種乳酸菌の生育試験を行った。試験に用いた
乳酸菌は、ストレプトコッカス・サーモフィルス (Stre
ptococcus thermophilus) SBT-1021A 株 (FERM P-1065
8) 、ラクトバチルス・アシドフィルス (Lactobacillus
acidophilus) SBT-2062 株 (FERM P-10730) 、ラクト
バチルス・ブルガリクス (Lactobacillus bulgaricus)
SBT-2118B株 (FERM P-13955) 及びラクトバチルス・カ
ゼイ (Lactobacillus casei) SBT-2300 株 (FERM P-132
45) で、培地に 0.3%接種し、37℃で16時間培養を行っ
た。なお、用いた培地の組成は、それぞれ(1) 脱脂粉乳
11.03%、培地用ペプトン 1.0%及び精製水 87.97%、
(2) 脱脂粉乳 11.53%、培地用ペプトン 0.5%及び精製
水 87.97%、(3) 脱脂粉乳 12.03%及び精製水 87.97%
であった。培養後の酸度を表2に示す。Test Example 3 Using the peptone for a medium obtained in Example 3, growth tests of various lactic acid bacteria were carried out depending on the addition amount. The lactic acid bacteria used in the test were Streptococcus thermophilus ( Stre
ptococcus thermophilus ) SBT-1021A strain (FERM P-1065
8), Lactobacillus
acidophilus) SBT-2062 strain (FERM P-10730), Lactobacillus bulgaricus
SBT-2118B strain (FERM P-13955) and Lactobacillus casei SBT-2300 strain (FERM P-132
At 45), 0.3% of the medium was inoculated and cultured at 37 ° C for 16 hours. The composition of the medium used is (1) skim milk powder
11.03%, medium peptone 1.0% and purified water 87.97%,
(2) Nonfat dry milk 11.53%, medium peptone 0.5% and purified water 87.97%, (3) Nonfat dry milk 12.03% and purified water 87.97%
Met. The acidity after culturing is shown in Table 2.
【0017】[0017]
【表2】 (単位:%) ──────────────────────────────────── SBT-1021A SBT-2062 SBT-2118B SBT-2300 ──────────────────────────────────── 培地 (1) 1.05 1.57 1.52 0.83 培地 (2) 0.98 1.31 1.45 0.62 培地 (3) 0.91 0.85 1.20 0.33 (ペプトン無添加) ──────────────────────────────────── 表2から、いずれの乳酸菌に対しても、本発明の培地用
ペプトンは、その含有量が多くなるに従い、その効果が
増すことが分かる。[Table 2] (Unit:%) ──────────────────────────────────── SBT-1021A SBT- 2062 SBT-2118B SBT-2300 ──────────────────────────────────── Medium (1) 1.05 1.57 1.52 0.83 Medium (2) 0.98 1.31 1.45 0.62 Medium (3) 0.91 0.85 1.20 0.33 (without peptone added) ───────────────────────────── ──────── From Table 2, it can be seen that the effect of the peptone for the medium of the present invention increases with increasing content of any of the lactic acid bacteria.
【0018】試験例4 実施例3及び比較例2〜3で得られた培地用ペプトンを
用い、ビフィズス菌の生育試験を行った。試験に用いた
ビフィズス菌は、ビフィドバクテリウム・ロンガム (Bi
fidobacterium longum) SBT-2928株 (FERM P-10657) 及
びビフィドバクテリウム・ロンガム (Bifidobacterium
longum) SBT-2933R株 (FERM P-8743)の混合物で、培地
に 0.3%接種し、37℃で16時間培養を行った。なお、用
いた各々の培地の組成は、脱脂粉乳 11.53%、培地用ペ
プトン 0.5%、アスコルビン酸ナトリウム0.03%及び精
製水 87.94%であった。培養後の酸度、pH及び生菌数を
表3に示す。Test Example 4 Using the culture medium peptone obtained in Example 3 and Comparative Examples 2 to 3, a growth test of Bifidobacterium was performed. Bifidobacterium used in the test was Bifidobacterium longum ( Bi
fidobacterium longum ) SBT-2928 strain (FERM P-10657) and Bifidobacterium longum ( Bifidobacterium longum )
longum ) SBT-2933R strain (FERM P-8743) was inoculated into the medium at 0.3% and cultured at 37 ° C. for 16 hours. The composition of each medium used was skim milk powder 11.53%, medium peptone 0.5%, sodium ascorbate 0.03% and purified water 87.94%. Table 3 shows the acidity, pH, and viable cell count after culturing.
【0019】[0019]
【表3】 ──────────────────────────────────── 実施例3 比較例2 比較例3 比較例4 ──────────────────────────────────── 酸度(%) 1.40 1.28 1.24 1.30 pH 4.35 4.30 4.29 4.31 SBT-2928 生菌数 (cfu/ml) 1.9×109 7.8×108 7.4×108 9.2×108 SBT-2933R 生菌数 (cfu/ml) 2.4×109 1.0×109 9.9×108 1.0×109 ──────────────────────────────────── 表3から、本発明の培地用ペプトンは、従来の培地用ペ
フトンに比較してビフィズス菌の生育に高い効果を示し
ていることが分かる[Table 3] ──────────────────────────────────── Example 3 Comparative Example 2 Comparative Example 3 Comparative Example Example 4 ──────────────────────────────────── Acidity (%) 1.40 1.28 1.24 1.30 pH 4.35 4.30 4.29 4.31 SBT-2928 viable cell count (cfu / ml) 1.9 × 10 9 7.8 × 10 8 7.4 × 10 8 9.2 × 10 8 SBT-2933R viable cell count (cfu / ml) 2.4 × 10 9 1.0 × 10 9 9.9 × 10 8 1.0 × 10 9 ──────────────────────────────────── From Table 3, for the medium of the present invention It can be seen that peptone shows a higher effect on the growth of Bifidobacterium than conventional peptone for culture medium.
【0020】試験例5 実施例3及び比較例2〜3で得られた培地用ペプトンを
用い、各種乳酸菌の生育試験を行った。試験に用いた乳
酸菌は、ストレプトコッカス・サーモフィルス(Strepto
coccus thermophilus) SBT-1021A 株 (FERM P-10658)
、ラクトバチルス・アシドフィルス (Lactobacillus a
cidophilus) SBT-2062 株 (FERM P-10730) 、ラクトバ
チルス・ブルガリクス (Lactobacillus bulgaricus) SB
T-2118B 株(FERM P-13955) 及びラクトバチルス・カゼ
イ (Lactobacillus casei) SBT-2300 株 (FERM P-1324
5) で、培地に 0.3%接種し、37℃で16時間培養を行っ
た。なお、用いた培地の組成は、脱脂粉乳 11.53%、培
地用ペプトン 0.5%及び精製水87.97%であった。培養
後の各乳酸菌の酸度、pH及び生菌数を表4に示す。Test Example 5 Using the culture medium peptone obtained in Example 3 and Comparative Examples 2 to 3, growth tests of various lactic acid bacteria were conducted. The lactic acid bacteria used in the test were Streptococcus thermophilus ( Strepto
coccus thermophilus ) SBT-1021A strain (FERM P-10658)
, Lactobacillus a
cidophilus) SBT-2062 strain (FERM P-10730), Lactobacillus bulgaricus SB
T-2118B strain (FERM P-13955) and Lactobacillus casei SBT-2300 strain (FERM P-1324)
In step 5), 0.3% of the medium was inoculated and cultured at 37 ° C for 16 hours. The composition of the medium used was skim milk powder 11.53%, medium peptone 0.5%, and purified water 87.97%. Table 4 shows the acidity, pH, and viable cell count of each lactic acid bacterium after culturing.
【0021】[0021]
【表4】 ──────────────────────────────────── 実施例3 比較例2 比較例3 比較例4 ──────────────────────────────────── 酸度(%) 1.10 1.04 0.94 0.96 SBT-1021A pH 4.10 4.16 4.25 4.23 生菌数 (cfu/ml) 4.2×108 2.2×108 3.0×108 1.8×108 ──────────────────────────────────── 酸度(%) 1.30 1.10 1.20 1.20 SBT-2062 pH 3.95 4.12 3.98 4.01 生菌数 (cfu/ml) 9.2×108 4.4×108 7.6×108 7.8×108 ──────────────────────────────────── 酸度(%) 1.58 1.50 1.42 1.46 SBT-2118B pH 3.77 3.71 3.67 3.68 生菌数 (cfu/ml) 3.4×108 2.8×108 1.0×108 1.0×108 ──────────────────────────────────── 酸度(%) 0.98 0.76 0.80 0.84 SBT-2300 pH 4.54 4.65 4.50 4.49 生菌数 (cfu/ml) 4.1×109 2.9×109 2.6×109 2.6×109 ──────────────────────────────────── 表4から明らかなように、本発明のローヤルゼリー由来
の蛋白質を酵素処理した加水分解物を用いた培地は、カ
ゼイン加水分解物や大豆蛋白質加水分解物を用いた培地
よりも乳酸菌培養物の酸度が高く、しかも乳酸菌の生菌
数も2〜3倍高いことが確認され、生育促進効果が高か
った。[Table 4] ──────────────────────────────────── Example 3 Comparative Example 2 Comparative Example 3 Comparative Example Example 4 ──────────────────────────────────── Acidity (%) 1.10 1.04 0.94 0.96 SBT-1021A pH 4.10 4.16 4.25 4.23 Viable cell count (cfu / ml) 4.2 × 10 8 2.2 × 10 8 3.0 × 10 8 1.8 × 10 8 ──────────────────────── ────────────── Acidity (%) 1.30 1.10 1.20 1.20 SBT-2062 pH 3.95 4.12 3.98 4.01 Viable cell count (cfu / ml) 9.2 × 10 8 4.4 × 10 8 7.6 × 10 8 7.8 × 10 8 ──────────────────────────────────── Acidity (%) 1.58 1.50 1.42 1.46 SBT- 2118B pH 3.77 3.71 3.67 3.68 Viable cell count (cfu / ml) 3.4 × 10 8 2.8 × 10 8 1.0 × 10 8 1.0 × 10 8 ───────────────────── ────────────── ─ acidity (%) 0.98 0.76 0.80 0.84 SBT -2300 pH 4.54 4.65 4.50 4.49 number of living bacteria (cfu / ml) 4.1 × 10 9 2.9 × 10 9 2.6 × 10 9 2.6 × 10 9 ───────── ─────────────────────────── As is clear from Table 4, the hydrolyzate obtained by enzymatically treating the royal jelly-derived protein of the present invention was used. It was confirmed that the medium used had a higher acidity of the lactic acid bacterium culture than the medium using casein hydrolyzate or soybean protein hydrolyzate, and the viable cell count of lactic acid bacteria was 2-3 times higher. it was high.
【0022】[0022]
【発明の効果】本発明のローヤルゼリー由来の蛋白質を
酵素で処理した蛋白質加水分解物は、カゼインや大豆蛋
白質の加水分解物よりも微生物に対して高い生育促進効
果を有するので、微生物を培養する培地にペプトンとし
て配合することにより、菌の増殖あるいは発酵促進効果
を得ることができる。また、原料として用いることので
きるローヤルゼリー由来の蛋白質は、従来、廃棄されて
いたものであり、資源の有効活用を図ることができる。The protein hydrolyzate obtained by treating the royal jelly-derived protein of the present invention with an enzyme has a higher growth-promoting effect on microorganisms than the hydrolyzate of casein or soybean protein, and therefore is a medium for culturing microorganisms. By adding peptone as a peptone, the effect of accelerating the growth or fermentation of bacteria can be obtained. In addition, the protein derived from royal jelly that can be used as a raw material has been conventionally discarded, and it is possible to effectively utilize resources.
Claims (2)
分解物からなる微生物培養培地用ペプトン。1. A peptone for a microorganism culture medium, which comprises an enzymatic hydrolyzate of a protein derived from royal jelly.
ルゼリーを膜処理して得られたものである請求項1記載
の微生物培養培地用ペプトン。2. The peptone for a microorganism culture medium according to claim 1, wherein the protein derived from royal jelly is obtained by subjecting royal jelly to a membrane treatment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6085567A JPH07265066A (en) | 1994-03-31 | 1994-03-31 | Peptone for culture medium for culturing microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6085567A JPH07265066A (en) | 1994-03-31 | 1994-03-31 | Peptone for culture medium for culturing microorganism |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH07265066A true JPH07265066A (en) | 1995-10-17 |
Family
ID=13862395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6085567A Pending JPH07265066A (en) | 1994-03-31 | 1994-03-31 | Peptone for culture medium for culturing microorganism |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07265066A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012080828A (en) * | 2010-10-12 | 2012-04-26 | Kato Bihoen Honpo:Kk | Royal jelly |
JP2014068599A (en) * | 2012-09-28 | 2014-04-21 | Morikawa Kenkodo Kk | Method of producing royal jelly having lactobacillus proliferation promoting action |
CN113040394A (en) * | 2021-04-19 | 2021-06-29 | 江苏鸿祺生物科技有限公司 | Royal jelly polypeptide and preparation method and application thereof |
-
1994
- 1994-03-31 JP JP6085567A patent/JPH07265066A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012080828A (en) * | 2010-10-12 | 2012-04-26 | Kato Bihoen Honpo:Kk | Royal jelly |
JP2014068599A (en) * | 2012-09-28 | 2014-04-21 | Morikawa Kenkodo Kk | Method of producing royal jelly having lactobacillus proliferation promoting action |
CN113040394A (en) * | 2021-04-19 | 2021-06-29 | 江苏鸿祺生物科技有限公司 | Royal jelly polypeptide and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0323201B1 (en) | Method for producing processed milk containing galactooligosaccharide | |
CA2984986C (en) | Method of culturing akkermansia | |
KR101604633B1 (en) | Medium composition for culturing lactic acid bacteria and producing method of powder of lactic acid bacteria using the same | |
Tran et al. | Isolation and characteristics of Bacillus subtilis CN2 and its collagenase production | |
JP5553434B2 (en) | Lactic acid bacteria survival improver, survival improvement method, and food composition | |
US20150152378A1 (en) | Method of double-coating lactic acid bacteria | |
FR2723960A1 (en) | Prodn. of Streptococcus thermophilus cultures rich in beta-galactosidase | |
Polak-Berecka et al. | Production of exopolysaccharides by a probiotic strain of Lactobacillus rhamnosus: biosynthesis and purification methods | |
KR20020069863A (en) | Manufacturing method of Dual-coated Lactic acid bacteria powder using protein and polysaccharlde | |
JP2009296910A (en) | Bifidobacterium bacillus-containing composition and method for producing the bifidobacterium bacillus-containing composition | |
KR100429494B1 (en) | Manufacturing method of Protein- coated Lactic acid bacteria powder | |
KR20000070867A (en) | Bifidobacterium-fermented milk and process for producing the same | |
JP4115181B2 (en) | Method for enhancing immunostimulatory effect of lactic acid bacteria | |
JPH07265066A (en) | Peptone for culture medium for culturing microorganism | |
KR20210059497A (en) | Composition for promoting growth of Lactic acid bacteria and a culture medium for Lactic acid bacteria | |
JPH08336355A (en) | Starter of bulgaria yogurt and lactate article and its manufacture | |
JP4307026B2 (en) | Lactic acid bacteria growth promoter and process for producing the same | |
Malik et al. | Effect of some nutritional and environmental factors on extracellular protease production by Pseudomonas sp. B-25 | |
JP2000093166A (en) | Bacillus bifidus growth promoting substance derived from albumen, and food containing the substance | |
JPH0416145B2 (en) | ||
RU2622078C1 (en) | Method for combined enzyme beta-galactosidase production | |
CN112980816B (en) | Beta-galactosidase fermentation medium and preparation method and application thereof | |
JPH02215392A (en) | Production of galactooligosaccharide | |
KR0138703B1 (en) | Culturing method with enzyme treated soybean | |
KR100233616B1 (en) | A process for harvesting spores from culture broth of bacillus polyfermenticus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20031224 |